• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

ABR_Website_Image.jpg

— February 15, 2018

Valneva reports strong 2017 revenues driven by double digit product sales growth

Read more

— Stock information

@valnevase




















-
— July 26, 2017
Valneva and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus

Read more
— Financial Calendar

March 22, 2018
2017 Financial Statements

May 17, 2018
Q1 2018 Results

See all dates






JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



World Vaccine Congress
Washington, US
April 2-5, 2018


 
Please update your browser...